E2 ModerateModerate confidencePEM ?Cross-SectionalPeer-reviewedMachine draft
Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.
Nkiliza, Aurore, Parks, Megan, Cseresznye, Adam et al. · Journal of translational medicine · 2021 · DOI
Quick Summary
This study analyzed fatty substances in the blood of ME/CFS patients and healthy controls to see if they differ in ways that might explain symptoms. Researchers found that men and women with ME/CFS had different patterns of these blood fats compared to healthy people. Importantly, certain blood fats were connected to the severity of fatigue, headaches, and thinking difficulties, suggesting that problems with how the body processes fats may play a role in ME/CFS symptoms.
Why It Matters
This research provides evidence that ME/CFS involves dysregulated lipid metabolism, which may contribute to the characteristic symptoms of fatigue, pain, and cognitive impairment. Identifying biological markers like abnormal blood lipids could eventually lead to better diagnostic tools and targeted treatments for ME/CFS. The sex-specific differences discovered are particularly important given that ME/CFS affects more women than men.
Observed Findings
- Females with ME/CFS showed significantly decreased total phosphatidylethanolamine and hexosylceramides compared to healthy female controls.
- Males with ME/CFS showed increased hexosylceramides, monounsaturated phosphatidylethanolamine, phosphatidylinositol, and saturated triglycerides versus healthy male controls.
- Omega-6 linoleic acid-derived oxylipins were significantly elevated in male ME/CFS patients.
- Lower concentrations of certain lipids (oxylipins and ethanolamides) were associated with more severe headaches, fatigue, and cognitive difficulties.
- Three major lipid components (primarily phosphatidylcholine species) were negatively correlated with headache and fatigue severity in both sexes.
Inferred Conclusions
- Dysregulated plasma lipid metabolism represents a key feature of ME/CFS and differs significantly by biological sex.
- Abnormalities in phospholipids, hexosylceramides, and oxylipins may contribute to immune dysfunction and inflammation underlying ME/CFS pathology.
- Lipid profiles may serve as potential biomarkers for ME/CFS diagnosis and severity, particularly for tracking fatigue, pain, and cognitive symptoms.
- Further investigation of lipid metabolism pathways is necessary to understand how lipid dysregulation drives ME/CFS pathogenesis.
Remaining Questions
What This Study Does Not Prove
This study cannot prove that abnormal lipids cause ME/CFS symptoms—it only shows they are associated. The cross-sectional design means we cannot determine whether lipid changes precede symptom development or result from having the illness. Additionally, findings in this relatively small cohort require replication in larger, more diverse populations before clinical application.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Strong PhenotypingSex-Stratified